Baker Brothers Advisors is a financial organization, but much else isn't disclosed publicly about this company.
Phone: 212-339-5600
6667 Madison Ave
Floor 17
New York, 10021
New York, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2014-06-16 | Presidio Pharmaceuticals | Series D | $21.83M | Bay City Capital |
| 2013-04-01 | Aquinox Pharmaceuticals | Series C | $18M | Augment Investments, Johnson & Johnson Innovation, Pfizer Venture Investments, and Ventures West |
| 2011-08-05 | Presidio Pharmaceuticals | Debt | $3M | Bay City Capital, New Leaf Venture Partners, Panorama Capital, and Ventures West |
| 2011-03-21 | Synageva BioPharma | Series G | $25M | Four Rivers Group, Hunt BioVentures, New Leaf Venture Partners, Tullis Health Investors, and Yasuda Enterprise Development |
| 2010-06-17 | Aquinox Pharmaceuticals | Series B | $25M | BC Advantage Funds, Johnson & Johnson Innovation, Pfizer Venture Investments, and Ventures West |
